Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer | Synapse
March 3, 2026Open Access
Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer
Key Points
Folate receptor-alpha is identified as a promising target for radionuclide therapy in ovarian cancer.
This study highlights the importance of surface markers in tailoring cancer treatments, with a focus on radionuclide therapy.
A comprehensive evaluation of surface markers shows how they can be utilized for effective targeted therapy options.
These findings indicate the potential for developing targeted radionuclide therapies, warranting further investigation into their clinical applications.